April 23, 2021 — Use of the Johnson & Johnson COVID-19 vaccine ought to resume in the US for all adults, an advisory panel for the CDC voted Friday afternoon.
The vote was 10-4 with one abstention. The choices additionally consists of directions for a warning to be included with vials of the vaccine. It’s directed at girls beneath 50 who’ve an elevated threat of a uncommon however critical blood clot dysfunction referred to as thrombosis with thrombocytopenia syndrome (TTS).
As of April 21, 15 instances of TTS, all in girls and 13 of them in girls beneath 50, have been confirmed amongst 7.98 million doses of the J&J vaccine administered within the U.S. Three girls have died.
The FDA and CDC beneficial the pause on April 13 after experiences that 6 girls developed a uncommon blood clotting dysfunction 6 to 13 days after they obtained the J&J vaccine.
This story shall be up to date.